Sumatriptan Succinate Tablet, Film Coated
Product Images NDC 50090-5939

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 50090-5939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of sumatriptan succinate, showing its molecular arrangement with a sulfonamide group, an indole ring, a dimethylaminoethyl side chain, and the succinate component.*

FDA Label Image

Label Image (Lbl500905939)

Sumatriptan succinate 25 mg film-coated tablets packaging label from A-S Medication Solutions. The label includes the NDC 50090-5939-0, storage instructions to keep at 60 to 77 degrees Fahrenheit, and indicates the package contains 9 unit-of-use tablets. The label directs users to see the package insert for dosage information.*

FDA Label Image

Sumatriptan-figure-1 (Sumatriptan Figure 1)

A Kaplan-Meier plot showing the estimated probability of achieving initial headache response within 4 hours after treatment with oral sumatriptan at doses of 25 mg, 50 mg, and 100 mg compared to placebo. The x-axis represents time in minutes from the initial dose (0 to 240), and the y-axis shows the estimated probability of response from 0% to 100%. The graph illustrates higher response probabilities for sumatriptan doses relative to placebo over time.*

FDA Label Image

Sumatriptan-figure-2 (Sumatriptan Figure 2)

A Kaplan-Meier plot showing the estimated probability of patients taking a second dose of sumatriptan succinate tablets or other medication to treat migraine within 24 hours after an initial dose. The graph compares placebo and three sumatriptan succinate oral tablet doses: 25 mg, 50 mg, and 100 mg, plotting probability of remediation or rescue over time in hours from the initial dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.